Corvidia Therapeutics is a clinical stage company focused on the research, development and commercialization of transformative therapies for cardio-renal diseases.
After receiving seed funding from Sofinnova Partners in 2015, our company was founded around a pipeline of assets with best in class potential to make a positive impact on patients with cardio-renal diseases. Since then, we have raised $26 million in Series A fin...
Corvidia Therapeutics is a clinical stage company focused on the research, development and commercialization of transformative therapies for cardio-renal diseases.
After receiving seed funding from Sofinnova Partners in 2015, our company was founded around a pipeline of assets with best in class potential to make a positive impact on patients with cardio-renal diseases. Since then, we have raised $26 million in Series A financing led by Sofinnova Partners and Apple Tree Partners and, $60 million in Series B financing led by Venrock which included Andera Partners, Cormorant Asset Management, HBM Partners & Fresenius Medical Care Ventures.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.